Clinical trial
A Randomized Phase II Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma
NCT00515190 is registered in ClinicalTrials.gov with National Cancer Center, Korea as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- A Randomized Phase II Study of Continuous or Intermittent S-1 Combined With Oxaliplatin in Recurrent or Metastatic Gastric Carcinoma
- Lead sponsor
- National Cancer Center, Korea
- Phase
- Phase 2
- Overall status
- Unknown status
- Start date
- July 31, 2007
- Completion date
- August 31, 2010
- Enrollment
- 198 (estimated)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.